← FDA DRUG APPROVALS

FDA NDA · NDA019548

TORNALATE

Sponsor: SANOFI AVENTIS US

APPLICATION
NDA019548
TYPE
NDA
ORIGINAL APPROVAL
1992-02-19
LATEST ACTION
2007-12-07
ROUTE
INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

TORNALATEDiscontinued
BITOLTEROL MESYLATE 0.2% · SOLUTION · INHALATION

Approval history

2007-12-07Labeling · Supplement 3 · standardAP
2007-12-07Labeling · Supplement 4 · standardAP
1994-09-21Manufacturing (CMC) · Supplement 2 · standardAP
1994-02-02Labeling · Supplement 1 · standardAP
1992-02-19Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →